Illumina Spin-off to Develop Early-Detection Test
- PMID: 26873346
- DOI: 10.1158/2159-8290.CD-NB2016-015
Illumina Spin-off to Develop Early-Detection Test
Abstract
DNA-sequencing giant Illumina has formed a new company, called Grail, to develop liquid biopsies capable of spotting cancer before symptoms arise. The start-up is working on a low-cost "pan-cancer" test that can detect multiple cancer types early, which it hopes to introduce by 2019.
©2016 American Association for Cancer Research.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
